Homo sapiens Protein: OCRL | |||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Summary | |||||||||||||||||||||||||||||||
InnateDB Protein | IDBP-85574.5 | ||||||||||||||||||||||||||||||
Last Modified | 2014-10-13 [Report errors or provide feedback] | ||||||||||||||||||||||||||||||
Gene Symbol | OCRL | ||||||||||||||||||||||||||||||
Protein Name | oculocerebrorenal syndrome of Lowe | ||||||||||||||||||||||||||||||
Synonyms | INPP5F; LOCR; NPHL2; OCRL-1; OCRL1; | ||||||||||||||||||||||||||||||
Species | Homo sapiens | ||||||||||||||||||||||||||||||
Ensembl Protein | ENSP00000360154 | ||||||||||||||||||||||||||||||
InnateDB Gene | IDBG-85566 (OCRL) | ||||||||||||||||||||||||||||||
Protein Structure | |||||||||||||||||||||||||||||||
UniProt Annotation | |||||||||||||||||||||||||||||||
Function | Converts phosphatidylinositol 4,5-bisphosphate to phosphatidylinositol 4-phosphate. Also converts inositol 1,4,5- trisphosphate to inositol 1,4-bisphosphate and inositol 1,3,4,5- tetrakisphosphate to inositol 1,3,4-trisphosphate. May function in lysosomal membrane trafficking by regulating the specific pool of phosphatidylinositol 4,5-bisphosphate that is associated with lysosomes. Involved in primary cilia assembly. {ECO:0000269PubMed:22228094, ECO:0000269PubMed:22543976}. | ||||||||||||||||||||||||||||||
Subcellular Localization | Cytoplasmic vesicle, phagosome membrane {ECO:0000250}. Early endosome membrane. Membrane, clathrin-coated pit. Cell projection, cilium, photoreceptor outer segment. Cytoplasmic vesicle {ECO:0000250}. Endosome {ECO:0000250}. Golgi apparatus, trans-Golgi network {ECO:0000250}. Note=Also found on macropinosomes. | ||||||||||||||||||||||||||||||
Disease Associations | Lowe oculocerebrorenal syndrome (OCRL) [MIM:309000]: X- linked multisystem disorder affecting eyes, nervous system, and kidney. It is characterized by hydrophthalmia, cataract, mental retardation, vitamin D-resistant rickets, aminoaciduria, and reduced ammonia production by the kidney. Ocular abnormalities include cataract, glaucoma, microphthalmos, and decreased visual acuity. Developmental delay, hypotonia, behavior abnormalities, and areflexia are also present. Renal tubular involvement is characterized by impaired reabsorption of bicarbonate, amino acids, and phosphate. Musculoskeletal abnormalities such as joint hypermobility, dislocated hips, and fractures may develop as consequences of renal tubular acidosis and hypophosphatemia. Cataract is the only significant manifestation in carriers and is detected by slit-lamp examination. {ECO:0000269PubMed:10767176, ECO:0000269PubMed:10923037, ECO:0000269PubMed:19168822, ECO:0000269PubMed:20133602, ECO:0000269PubMed:21031565, ECO:0000269PubMed:21233288, ECO:0000269PubMed:9199559, ECO:0000269PubMed:9632163, ECO:0000269PubMed:9682219, ECO:0000269PubMed:9788721}. Note=The disease is caused by mutations affecting the gene represented in this entry.Dent disease 2 (DD2) [MIM:300555]: A renal disease belonging to the 'Dent disease complex', a group of disorders characterized by proximal renal tubular defect, hypercalciuria, nephrocalcinosis, and renal insufficiency. The spectrum of phenotypic features is remarkably similar in the various disorders, except for differences in the severity of bone deformities and renal impairment. Characteristic abnormalities include low-molecular-weight proteinuria and other features of Fanconi syndrome, such as glycosuria, aminoaciduria, and phosphaturia, but typically do not include proximal renal tubular acidosis. Progressive renal failure is common, as are nephrocalcinosis and kidney stones. {ECO:0000269PubMed:15627218, ECO:0000269PubMed:17384968, ECO:0000269PubMed:21031565}. Note=The disease is caused by mutations affecting the gene represented in this entry. | ||||||||||||||||||||||||||||||
Tissue Specificity | Brain, skeletal muscle, heart, kidney, lung, placenta and fibroblasts. Expressed in the retina and the retinal pigment epithelium. {ECO:0000269PubMed:22543976}. | ||||||||||||||||||||||||||||||
Comments | |||||||||||||||||||||||||||||||
Interactions | |||||||||||||||||||||||||||||||
Number of Interactions |
This gene and/or its encoded proteins are associated with 34 experimentally validated interaction(s) in this database.
|
||||||||||||||||||||||||||||||
Gene Ontology | |||||||||||||||||||||||||||||||
Molecular Function |
|
||||||||||||||||||||||||||||||
Biological Process |
|
||||||||||||||||||||||||||||||
Cellular Component |
|
||||||||||||||||||||||||||||||
Protein Structure and Domains | |||||||||||||||||||||||||||||||
PDB ID | |||||||||||||||||||||||||||||||
InterPro |
IPR000198
Rho GTPase-activating protein domain IPR000300 Inositol polyphosphate-related phosphatase IPR005135 Endonuclease/exonuclease/phosphatase IPR008936 Rho GTPase activation protein |
||||||||||||||||||||||||||||||
PFAM |
PF00620
PF03372 PF14529 |
||||||||||||||||||||||||||||||
PRINTS | |||||||||||||||||||||||||||||||
PIRSF | |||||||||||||||||||||||||||||||
SMART |
SM00324
SM00128 |
||||||||||||||||||||||||||||||
TIGRFAMs | |||||||||||||||||||||||||||||||
Post-translational Modifications | |||||||||||||||||||||||||||||||
Modification | |||||||||||||||||||||||||||||||
Cross-References | |||||||||||||||||||||||||||||||
SwissProt | Q01968 | ||||||||||||||||||||||||||||||
PhosphoSite | PhosphoSite-Q01968 | ||||||||||||||||||||||||||||||
TrEMBL | |||||||||||||||||||||||||||||||
UniProt Splice Variant | |||||||||||||||||||||||||||||||
Entrez Gene | 4952 | ||||||||||||||||||||||||||||||
UniGene | Hs.126357 | ||||||||||||||||||||||||||||||
RefSeq | NP_000267 | ||||||||||||||||||||||||||||||
HUGO | HGNC:8108 | ||||||||||||||||||||||||||||||
OMIM | 300535 | ||||||||||||||||||||||||||||||
CCDS | CCDS35393 | ||||||||||||||||||||||||||||||
HPRD | 02395 | ||||||||||||||||||||||||||||||
IMGT | |||||||||||||||||||||||||||||||
EMBL | AK293107 AL022162 AL138745 AL662877 BC130612 BC144106 CH471107 M88162 S62085 U57627 Z73496 | ||||||||||||||||||||||||||||||
GenPept | AAA59964 AAB03839 AAB26926 AAI30613 AAI44107 BAF85796 CAI41087 CAI41088 CAI42615 CAI42616 CAI95695 CAI95696 EAX11831 EAX11832 | ||||||||||||||||||||||||||||||